Most Recent
Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca's cholesterol drug Crestor, two-and-a-half years after the High Court of Australia found the patent obvious and invalid.
Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline's legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival's Panadol.
Alcohol, anti-depressants and the common use of bad language at the Illawarra coal mine did not excuse a sacked miner's threatening and expletive-laced phone calls to colleagues, the full Fair Work Commission has found.
Auditing firm Pitcher Partners has filed its defence in a class action accusing it of wrongly signing off on Slater & Gordon's financial reports, denying responsibility for alleged material misstatements that investors say they relied on to their detriment.
The Bank of Queensland has reached a settlement close to trial in a class action brought by investors in a multi-million dollar Ponzi scheme masterminded by jailed scammer Bradley Sherwin.
The CFMEU has a "deplorable record" of breaking industrial legislation, a Federal Court judge said Monday as it slapped the union and a Victorian delegate with a $105,000 fine for enforcing a closed union construction site in Melbourne.
In a win for aviation services company Aerocare, a court on Friday ruled the company's bid for review of its controversial split-shift rosters was not an abuse of process as two unions had argued.
A judge has rejected Amaca's bid for indemnity costs in a case over contributions to an asbestos class action settlement, but he did not rule on the company's novel argument that a settlement resulting from mediation could count as the outcome of litigation in awarding costs.
IP Australia handed a win Thursday to a company challenging a Bayer animal drug patent, but gave Bayer an additional two months to address its concerns about the patent application's deficiencies.
The Commonwealth Bank of Australia on Friday pushed back against the majority of expanded claims brought by the anti-money laundering regulator and denied all allegations in the related class action.